SQZ Biotechnologies Company (OTCMKTS:SQZB) Sees Large Decrease in Short Interest

SQZ Biotechnologies Company (OTCMKTS:SQZB) was the recipient of a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 6,479 shares, a decrease of 65.7% from the September 15th total of 18,887 shares. Based on an average daily volume of 4,824 shares, the short-interest ratio is currently 1.3 days. Currently, 0.0% of the company’s stock are short sold.

SQZ Biotechnologies Stock Performance

Shares of OTCMKTS SQZB opened at $0.02 on Tuesday. The stock has a fifty day moving average price of $0.02 and a 200 day moving average price of $0.02. SQZ Biotechnologies has a 12-month low of $0.02 and a 12-month high of $0.05. The company has a market cap of $707,760.00, a P/E ratio of -0.04 and a beta of 0.38.

About SQZ Biotechnologies

SQZ Biotechnologies Co was a biotechnology company that developed cell therapies using its proprietary Cell Squeeze platform. The technology was designed to deliver biological materials, including proteins, nucleic acids and other therapeutic agents, directly into cells without relying on conventional viral vectors.

The company focused primarily on oncology and immune-mediated diseases. Its research programs included engineered immune-cell therapies intended to recognize and attack cancer, as well as approaches designed to enhance the function of immune cells.